Your browser doesn't support javascript.
loading
Management of Resectable Stage III-N2 Non-Small-Cell Lung Cancer (NSCLC) in the Age of Immunotherapy.
Mielgo-Rubio, Xabier; Montemuiño, Sara; Jiménez, Unai; Luna, Javier; Cardeña, Ana; Mezquita, Laura; Martín, Margarita; Couñago, Felipe.
Afiliação
  • Mielgo-Rubio X; Department of Medical Oncology, Hospital Universitario Fundación Alcorcón, 28922 Madrid, Spain.
  • Montemuiño S; Department of Radiation Oncology, Hospital Universitario Fuenlabrada, 28942 Madrid, Spain.
  • Jiménez U; Department of Thoracic Surgery, Hospital Universitario Cruces, 48903 Barakaldo, Bizkaia, Spain.
  • Luna J; Department of Radiation Oncology, Fundación Jiménez Díaz, 28040 Madrid, Spain.
  • Cardeña A; Department of Medical Oncology, Hospital Universitario Fundación Alcorcón, 28922 Madrid, Spain.
  • Mezquita L; Department of Medical Oncology, Hospital Universitari Clínic Barcelona, 08036 Barcelona, Spain.
  • Martín M; Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
  • Couñago F; Department of Radiation Oncology, Hospital Universitario Quirónsalud Madrid, 28223 Madrid, Spain.
Cancers (Basel) ; 13(19)2021 Sep 26.
Article em En | MEDLINE | ID: mdl-34638296
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha